Neurocrine Biosciences Market Cap

Neurocrine Biosciences has a market cap or net worth of $17.85 billion as of July 21, 2026. Its market cap has increased by 36.65% in one year.

Market Cap

17.85B

Enterprise Value

16.96B

1-Year Change

36.65%

Ranking

#656

ChartMarket Cap Chart

Chart

Since December 1, 1998, Neurocrine Biosciences's market cap has increased from $124.10M to $17.85B, an increase of 14,286.51%. That is a compound annual growth rate of 19.68%.

Market Cap History

Date	Market Cap	% Change
Jul 21, 2026	17.85B	26.25%
Dec 31, 2025	14.14B	2.32%
Dec 31, 2024	13.82B	6.76%
Dec 29, 2023	12.95B	12.74%
Dec 30, 2022	11.48B	42.11%
Dec 31, 2021	8.08B	-9.78%
Dec 31, 2020	8.96B	-9.54%
Dec 31, 2019	9.90B	52.87%
Dec 31, 2018	6.48B	-5.69%
Dec 29, 2017	6.87B	104.24%
Dec 30, 2016	3.36B	-31.05%
Dec 31, 2015	4.88B	187.17%
Dec 31, 2014	1.70B	169.95%
Dec 31, 2013	629.00M	26.66%
Dec 31, 2012	496.60M	5.73%
Dec 30, 2011	469.70M	12.07%
Dec 31, 2010	419.10M	293.15%
Dec 31, 2009	106.60M	-13.68%
Dec 31, 2008	123.50M	-28.41%
Dec 31, 2007	172.50M	-56.31%
Dec 29, 2006	394.80M	-82.96%
Dec 30, 2005	2.32B	28.86%
Dec 31, 2004	1.80B	-6.54%
Dec 31, 2003	1.92B	37.67%
Dec 31, 2002	1.40B	3.88%

View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Haleon	43.86B
Teva Pharmaceutical Industries	36.24B
Zoetis	31.60B
United Therapeutics	22.35B
Viatris	19.86B
Elanco Animal Health	12.58B
Dr. Reddy's Laboratories	10.42B
Alkermes	8.62B

Market Cap Rankings